{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:28:48Z","timestamp":1761316128388,"version":"build-2065373602"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science Foundation of Peking University Cancer Hospital","award":["BJCH2024CZ02"],"award-info":[{"award-number":["BJCH2024CZ02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-025-00945-2","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:22:24Z","timestamp":1761315744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic value of 18F-FDG PET\/CT in the follow-up of metastatic uveal melanoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Huan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daxi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"2","key":"945_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/PPO.0000000000000708","volume":"30","author":"M Barbi","year":"2024","unstructured":"Barbi M, Carvajal RD, Devoe CE. Updates in the management of uveal melanoma. Cancer J. 2024;30(2):92\u2013101.","journal-title":"Cancer J"},{"issue":"5","key":"945_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ctrv.2012.01.002","volume":"38","author":"F Spagnolo","year":"2012","unstructured":"Spagnolo F, Caltabiano G, Queirolo P. Uveal melanoma. Cancer Treat Rev. 2012;38(5):549\u201353.","journal-title":"Cancer Treat Rev"},{"key":"945_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13111836","author":"A Sajan","year":"2023","unstructured":"Sajan A, Fordyce S, Sideris A, Liou C, Toor Z, Filtes J, et al. Minimally invasive treatment options for hepatic uveal melanoma metastases. Diagnostics (Basel). 2023. https:\/\/doi.org\/10.3390\/diagnostics13111836.","journal-title":"Diagnostics (Basel)"},{"issue":"12","key":"945_CR4","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1200\/JCO.2004.08.194","volume":"22","author":"M Diener-West","year":"2004","unstructured":"Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Screening for metastasis from choroidal melanoma: the collaborative ocular melanoma study group report 23. J Clin Oncol. 2004;22(12):2438\u201344.","journal-title":"J Clin Oncol"},{"issue":"5","key":"945_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/ceo.14214","volume":"51","author":"H Bai","year":"2023","unstructured":"Bai H, Bosch JJ, Heindl LM. Current management of uveal melanoma: a review. Clin Experiment Ophthalmol. 2023;51(5):484\u201394.","journal-title":"Clin Experiment Ophthalmol"},{"issue":"8","key":"945_CR6","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/annonc\/mdz176","volume":"30","author":"L Khoja","year":"2019","unstructured":"Khoja L, Atenafu EG, Suciu S, Leyvraz S, Sato T, Marshall E, et al. Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study. Ann Oncol. 2019;30(8):1370\u201380.","journal-title":"Ann Oncol"},{"key":"945_CR7","doi-asserted-by":"crossref","unstructured":"Solnik M, Paduszynska N, Czarnecka AM, Synoradzki KJ, Yousef YA, Choragiewicz T, Rejdak R, Toro MD, Zweifel S, Dyndor K et al. Imaging of uveal Melanoma-Current standard and methods in development. Cancers (Basel). 2022;14(13):3147.","DOI":"10.3390\/cancers14133147"},{"key":"945_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.617868","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Wang L, Zhang L, Tang F, Wei X. Application of multimodal and molecular imaging techniques in the detection of choroidal melanomas. Front Oncol. 2020;10:617868.","journal-title":"Front Oncol"},{"issue":"1","key":"945_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4103\/ijo.IJO_1478_21","volume":"70","author":"G Garg","year":"2022","unstructured":"Garg G, Kivela TT, Finger PT. Patients presenting with stage IV uveal melanoma: lessons learned. Indian J Ophthalmol. 2022;70(1):271\u20134.","journal-title":"Indian J Ophthalmol"},{"key":"945_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010215","author":"N Zamani-Siahkali","year":"2024","unstructured":"Zamani-Siahkali N, Mirshahvalad SA, Pirich C, Beheshti M. Diagnostic performance of [(18)F]F-FDG positron emission tomography (PET) in non-ophthalmic malignant melanoma: a systematic review and meta-analysis of more than 10,000 melanoma patients. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16010215.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"945_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0039-6257(04)00115-8","volume":"49","author":"LS Freudenberg","year":"2004","unstructured":"Freudenberg LS, Schueler AO, Beyer T, Antoch G, Kuhl H, Bornfeld N, Bockisch A, Egelhof. T Whole-body fluorine-18 fluordeoxyglucose positron emission tomography\/computed tomography (FDG-PET\/CT) in staging of advanced uveal melanoma. Surv Ophthalmol. 2004;49(5):537\u201340.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"945_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajo.2005.02.051","volume":"140","author":"M Kurli","year":"2005","unstructured":"Kurli M, Reddy S, Tena LB, Pavlick AC, Finger PT. Whole body positron emission tomography\/computed tomography staging of metastatic choroidal melanoma. Am J Ophthalmol. 2005;140(2):193\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"945_CR13","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1136\/bjo.2005.069823","volume":"89","author":"PT Finger","year":"2005","unstructured":"Finger PT, Kurli M, Reddy S, Tena LB, Pavlick AC. Whole body PET\/CT for initial staging of choroidal melanoma. Br J Ophthalmol. 2005;89(10):1270\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"945_CR14","first-page":"37","volume":"76","author":"M Marko","year":"2020","unstructured":"Marko M, Lesko P, Jurenova D, Furda R, Gregus M. Importance of PET\/CT examination in patients with malignant uveal melanoma. Cesk Slov Oftalmol. 2020;76(1):37\u201344.","journal-title":"Cesk Slov Oftalmol"},{"key":"945_CR15","doi-asserted-by":"crossref","unstructured":"Rodriguez-Vidal C, Fernandez-Diaz D, Fernandez-Marta B, Lago-Baameiro N, Pardo M, Silva P, Paniagua L, Blanco-Teijeiro MJ. Pineiro A, and Bande M treatment of metastatic uveal melanoma. Syst Rev Cancers (Basel). 2020;12(9):2557.","DOI":"10.3390\/cancers12092557"},{"issue":"6","key":"945_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/CMR.0b013e3283403d6c","volume":"20","author":"A Klingenstein","year":"2010","unstructured":"Klingenstein A, Haug AR, Nentwich MM, Tiling R, Schaller UC, Whole-body. F-18-fluoro-2-deoxyglucose positron emission tomography\/computed tomography imaging in the follow-up of metastatic uveal melanoma. Melanoma Res. 2010;20(6):511\u20136.","journal-title":"Melanoma Res"},{"issue":"1","key":"945_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/CMR.0b013e32834d3dcb","volume":"22","author":"V Orcurto","year":"2012","unstructured":"Orcurto V, Denys A, Voelter V, Schalenbourg A, Schnyder P, Zografos L, et al. (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study. Melanoma Res. 2012;22(1):63\u20139.","journal-title":"Melanoma Res"},{"issue":"2","key":"945_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejso.2009.08.010","volume":"36","author":"V Servois","year":"2010","unstructured":"Servois V, Mariani P, Malhaire C, Petras S, Piperno-Neumann S, Plancher C, Levy-Gabriel C, Lumbroso-le Rouic L, Desjardins L, Salmon RJ. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET). Eur J Surg Oncol. 2010;36(2):189\u201394.","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"945_CR19","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s00259-009-1175-0","volume":"36","author":"K Strobel","year":"2009","unstructured":"Strobel K, Bode B, Dummer R, Veit-Haibach P, Fischer DR, Imhof L, Goldinger S, Steinert HC, von Schulthess. G K limited value of 18F-FDG PET\/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging. 2009;36(11):1774\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"945_CR20","doi-asserted-by":"publisher","first-page":"14062","DOI":"10.1002\/cam4.6058","volume":"12","author":"LP Del Carpio","year":"2023","unstructured":"Del Carpio LP, Algarra MA, Sabate-Llobera A, Rodriguez-Vida A, Rossi-Seoane S, Ruiz S, Leiva D, Ramos E, Llado L, Lorenzo D, et al. Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosis. Cancer Med. 2023;12(13):14062\u201371.","journal-title":"Cancer Med"},{"issue":"5","key":"945_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1346-8138.2005.tb00903.x","volume":"32","author":"K Yamada","year":"2005","unstructured":"Yamada K, Brink I, Bisse E, Epting T, Engelhardt R. Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity. J Dermatol. 2005;32(5):316\u201334.","journal-title":"J Dermatol"},{"issue":"5","key":"945_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1346-8138.2005.tb00904.x","volume":"32","author":"K Yamada","year":"2005","unstructured":"Yamada K, Brink I, Engelhardt R. Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) accumulation in melanoma cells: is FDG a substrate of multidrug resistance (MDR)? J Dermatol. 2005;32(5):335\u201345.","journal-title":"J Dermatol"},{"issue":"11","key":"945_CR23","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s00330-012-2499-x","volume":"22","author":"ME Mayerhoefer","year":"2012","unstructured":"Mayerhoefer ME, Prosch H, Herold CJ, Weber M, Karanikas G. Assessment of pulmonary melanoma metastases with 18F-FDG PET\/CT: which PET-negative patients require additional tests for definitive staging? Eur Radiol. 2012;22(11):2451\u20137.","journal-title":"Eur Radiol"},{"issue":"2","key":"945_CR24","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1097\/RLU.0000000000003319","volume":"46","author":"A Shariftabrizi","year":"2021","unstructured":"Shariftabrizi A, Pillenahalli Maheshwarappa R, Kahn D, Pollard. J 18F-Fluciclovine-Avid mediastinal lymph node metastasis of cutaneous malignant melanoma. Clin Nucl Med. 2021;46(2):e97\u20139.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"945_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/RLU.0000000000001789","volume":"42","author":"EJ Teoh","year":"2017","unstructured":"Teoh EJ, Tsakok MT, Bradley KM, Hyde K, Subesinghe M, Gleeson FV. Recurrent malignant melanoma detected on 18F-fluciclovine PET\/CT imaging for prostate cancer. Clin Nucl Med. 2017;42(10):803\u20134.","journal-title":"Clin Nucl Med"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00945-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-025-00945-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00945-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:22:25Z","timestamp":1761315745000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-025-00945-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1186\/s40644-025-00945-2","relation":{},"ISSN":["1470-7330"],"issn-type":[{"type":"electronic","value":"1470-7330"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}